CalPERS puts weight behind opposing biosimilar medication notification bill

California’s giant pension fund weighed in on biosimilar medications Wednesday, suggesting the stakes are high before they are even approved for sale...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.